To screen or not to screen for osteoporosis amongst post-menopausal women with one prior osteoporotic fracture in Greece

被引:1
|
作者
Souliotis, Kyriakos [1 ,2 ]
Golna, Christina [2 ]
Golnas, Paul [2 ]
Markakis, Ioannis-Anestis [2 ]
Makras, Polyzois [3 ,4 ]
机构
[1] Univ Peloponnese, Dept Social & Educ Policy, Corinth, Greece
[2] Hlth Policy Inst, Maroussi, Greece
[3] 251 Hellen Air Force & VA Gen Hosp, Dept Endocrinol & Diabet, Athens, Greece
[4] 251 Hellenic Air Force & VA Gen Hosp, Dept Med Res, Athens, Greece
关键词
Osteoporosis burden; Postmenopausal; Osteoporotic fractures; Modelling; Screening; Cost of care; COST-EFFECTIVENESS; RISK; MORTALITY;
D O I
10.1007/s40520-022-02183-z
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background Screening and linkage to care (SLTC) for osteoporosis is suboptimal in several settings. In Greece, it is estimated that only up to 8.6% of postmenopausal women are SLTC for osteoporosis, despite having suffered a previous fracture. Aims This study aims to estimate the impact of comprehensive screening on future fracture burden amongst post-menopausal women aged 50-74, with one prior osteoporotic fracture, in Greece. Methods We developed a cohort stochastic model, based on published epidemiological and clinical data, to assess impact of screening on future fracture burden in two scenarios: a current, assuming an 8.6% background SLTC, and a completely hypothetical, assuming 100% SLTC. Results Amongst a cohort of 50,000 post-menopausal women aged 50-74, with one prior osteoporotic fracture, applying the hypothetical versus the current scenario would result in a reduction in deaths (-0.6%) and fractures (-4.3%) over 10 years. The hypothetical scenario leads to greater reductions in costs associated with vertebral (-8.1%) and hip (-5.5%) fractures, followed by other non-vertebral (-3.0%) and forearm (-2.5%) fractures. In the hypothetical scenario, treatment initiations and total screenings increased almost tenfold versus the current scenario, at an estimated direct incremental cost of 27.83euro per woman per year in the cohort. Discussion Our study adds to the existing evidence on the impact of screening to prevent fractures amongst post-menopausal women. Despite being based on a stochastic model, our study confirms findings most recently published in the literature. Conclusions Our study models the positive public health impact of increasing SLTC levels amongst post-menopausal women with a prior osteoporotic fracture.
引用
收藏
页码:2473 / 2481
页数:9
相关论文
共 36 条
  • [31] Potential for bone turnover markers to cost-effectively identify and select post-menopausal osteopenic women at high risk of fracture for bisphosphonate therapy
    J. T. Schousboe
    D. C. Bauer
    J. A. Nyman
    R. L. Kane
    L. J. Melton
    K. E. Ensrud
    Osteoporosis International, 2007, 18 : 201 - 210
  • [32] The effect of regular physical activity on bone mineral density in post-menopausal women aged 75 and over: a retrospective analysis from the Canadian multicentre osteoporosis study
    Jeffrey M Muir
    Chenglin Ye
    Mohit Bhandari
    Jonathan D Adachi
    Lehana Thabane
    BMC Musculoskeletal Disorders, 14
  • [33] The effect of regular physical activity on bone mineral density in post-menopausal women aged 75 and over: a retrospective analysis from the Canadian multicentre osteoporosis study
    Muir, Jeffrey M.
    Ye, Chenglin
    Bhandari, Mohit
    Adachi, Jonathan D.
    Thabane, Lehana
    BMC MUSCULOSKELETAL DISORDERS, 2013, 14
  • [34] The Relation Between Osteoporosis and Bone Fractures and Health-Related Quality of Life in Post-menopausal Saudi Women in the Jazan Region: A Cross-Sectional Study
    El-Setouhy, Maged
    Khired, Zenat
    Darraj, Hussam
    Zogel, Basem
    Alhazmi, Mohammed H.
    Maghrabi, Rawan E.
    Sayegh, Maram
    Akkur, Ahmed A.
    Bakri, Nawaf
    Alhazmi, Asma
    Zaino, Mohammad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [35] Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
    Kendler, David L.
    Marin, Fernando
    Zerbini, Cristiano A. F.
    Russo, Luis A.
    Greenspan, Susan L.
    Zikan, Vit
    Bagur, Alicia
    Malouf-Sierra, Jorge
    Lakatos, Peter
    Fahrleitner-Pammer, Astrid
    Lespessailles, Eric
    Minisola, Salvatore
    Body, Jean Jacques
    Geusens, Piet
    Moericke, Ruediger
    Lopez-Romero, Pedro
    LANCET, 2018, 391 (10117) : 230 - 240
  • [36] Interrelations between clinical-psychological features and bone mineral density changes in post-menopausal women undergoing anti-osteoporotic treatment: a two-year follow-up
    Martino, Gabriella
    Bellone, Federica
    Vicario, Carmelo Mario
    Gaudio, Agostino
    Corica, Francesco
    Squadrito, Giovanni
    Lund-Jacobsen, Trine
    Schwarz, Peter
    Lo Coco, Gianluca
    Morabito, Nunziata
    Catalano, Antonino
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14